Balance Labs, Inc.
OTC · CIK 0001632121 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$32,667
Operating Income
$-488,087
Net Income
$177,803
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $32,667 | - | - |
| Operating Income | $-488,087 | - | - |
| Net Income | $177,803 | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Cash And Equivalents | $216,366 | - | - |
| Total Assets | $259,662 | - | - |
| Total Liabilities | $3.1M | - | - |
| Shareholders Equity | $-2.9M | - | - |
| Operating Cash Flow | $-142,609 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Balance Labs, Inc. | 2026-05-15 | 0001493152-26-023451 |
| 10-K | Balance Labs, Inc. | 2026-04-10 | 0001493152-26-016088 |
| 10-Q | Balance Labs, Inc. | 2025-11-13 | 0001493152-25-022345 |
| 10-Q | Balance Labs, Inc. | 2025-08-14 | 0001641172-25-023738 |